Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9295299rdf:typepubmed:Citationlld:pubmed
pubmed-article:9295299lifeskim:mentionsumls-concept:C0054450lld:lifeskim
pubmed-article:9295299lifeskim:mentionsumls-concept:C0040691lld:lifeskim
pubmed-article:9295299lifeskim:mentionsumls-concept:C1413103lld:lifeskim
pubmed-article:9295299lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:9295299lifeskim:mentionsumls-concept:C0173545lld:lifeskim
pubmed-article:9295299pubmed:issue38lld:pubmed
pubmed-article:9295299pubmed:dateCreated1997-10-23lld:pubmed
pubmed-article:9295299pubmed:abstractTextTransforming growth factor beta (TGF-beta) is a pluripotent peptide hormone that regulates various cellular activities, including growth, differentiation, and extracellular matrix protein gene expression. We previously showed that TGF-beta induces the transcriptional activation domain (TAD) of CTF-1, the prototypic member of the CTF/NF-I family of transcription factors. This induction correlates with the proposed role of CTF/NF-I binding sites in collagen gene induction by TGF-beta. However, the mechanisms of TGF-beta signal transduction remain poorly understood. Here, we analyzed the role of free calcium signaling in the induction of CTF-1 transcriptional activity by TGF-beta. We found that TGF-beta stimulates calcium influx and mediates an increase of the cytoplasmic calcium concentration in NIH3T3 cells. TGF-beta induction of CTF-1 is inhibited in cells pretreated with thapsigargin, which depletes the endoplasmic reticulum calcium stores, thus further arguing for the potential relevance of calcium mobilization in TGF-beta action. Consistent with this possibility, expression of a constitutively active form of the calcium/calmodulin-dependent phosphatase calcineurin or of the calcium/calmodulin-dependent kinase IV (DeltaCaMKIV) specifically induces the CTF-1 TAD and the endogenous mouse CTF/NF-I proteins. Both calcineurin- and DeltaCaMKIV-mediated induction require the previously identified TGF-beta-responsive domain of CTF-1. The immunosuppressants cyclosporin A and FK506 abolish calcineurin-mediated induction of CTF-1 activity. However, TGF-beta still induces the CTF-1 TAD in cells treated with these compounds or in cells overexpressing both calcineurin and DeltaCaMKIV, suggesting that other calcium-sensitive enzymes might mediate TGF-beta action. These results identify CTF/NF-I as a novel calcium signaling pathway-responsive transcription factor and further suggest multiple molecular mechanisms for the induction of CTF/NF-I transcriptional activity by growth factors.lld:pubmed
pubmed-article:9295299pubmed:languageenglld:pubmed
pubmed-article:9295299pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:citationSubsetIMlld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9295299pubmed:statusMEDLINElld:pubmed
pubmed-article:9295299pubmed:monthSeplld:pubmed
pubmed-article:9295299pubmed:issn0021-9258lld:pubmed
pubmed-article:9295299pubmed:authorpubmed-author:MermodNNlld:pubmed
pubmed-article:9295299pubmed:authorpubmed-author:DusserreYYlld:pubmed
pubmed-article:9295299pubmed:authorpubmed-author:RüeggUUlld:pubmed
pubmed-article:9295299pubmed:authorpubmed-author:Alevizopoulos...lld:pubmed
pubmed-article:9295299pubmed:issnTypePrintlld:pubmed
pubmed-article:9295299pubmed:day19lld:pubmed
pubmed-article:9295299pubmed:volume272lld:pubmed
pubmed-article:9295299pubmed:ownerNLMlld:pubmed
pubmed-article:9295299pubmed:authorsCompleteYlld:pubmed
pubmed-article:9295299pubmed:pagination23597-605lld:pubmed
pubmed-article:9295299pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:meshHeadingpubmed-meshheading:9295299-...lld:pubmed
pubmed-article:9295299pubmed:year1997lld:pubmed
pubmed-article:9295299pubmed:articleTitleRegulation of the transforming growth factor beta-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV.lld:pubmed
pubmed-article:9295299pubmed:affiliationLaboratory of Molecular Biotechnology, Center of Biotechnology UNIL-EPFL, DC-IGC, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.lld:pubmed
pubmed-article:9295299pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9295299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9295299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9295299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9295299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9295299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9295299lld:pubmed